We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lyme Disease Antibodies Attached to Nanotubes

By LabMedica International staff writers
Posted on 10 Apr 2013
A fast and accurate sensor for a Lyme disease antigen has been developed that may pave the way for a diagnostic device. More...


The potential of antibody-functionalized single-walled carbon nanotube (SWNT) field-effect transistors (FETs) has been examined which may lead to diagnostics that can detect the organism itself.

Scientists at the University of Pennsylvania (Philadelphia, PA, USA) fabricated the device and attached monoclonal Lyme antibodies specific for the Borrelia burgdorferi p41 flagellar antigen (antibodies-online Inc.; Atlanta, GA, USA) and histidine tagged Lyme antigen containing the p41 flagellar immunodominant region which is also known as flagellin (ProSpec; East Brunswick, NJ, USA). Attachment of B. burgdorferi (Lyme) flagellar antibodies to the nanotubes was verified by atomic force microscopy and electronic measurements.

After using atomic-force microscopy to show that antibodies had indeed bound to the exteriors of their nanotube transistors, the investigators tested them electrically to get a baseline reading. They then put the nanotubes in solutions that contained different concentrations of the target Lyme bacteria protein. The smallest concentration the nanotube devices could detect was four ng/mL of protein of solution.

Early diagnosis is critical in treating Lyme disease, nevertheless, nearly one quarter of Lyme disease patients are initially misdiagnosed because currently available serological tests have poor sensitivity and specificity during the early stages of infection. Misdiagnosed patients may go untreated and thus progress to late-stage Lyme disease, where they face longer and more invasive treatments, as well as persistent symptoms.

A.T. Charlie Johnson, PhD, a professor of physics and senior author of the study said, "If we were to do this type of test on a person's blood now, however, we would say the person has the disease. The first thought is that if you detect any protein coming from the Lyme organism in your blood, you are infected and should get treatment right away." The study was published online on February 4, 2013, in the journal Biosensors and Bioelectronics.

Related Links:
University of Pennsylvania
antibodies-online Inc.
ProSpec



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
New
POC Immunoassay Analyzer
Procise DX
New
Automated Coagulation Analyzer
Hemolumi H6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more

Molecular Diagnostics

view channel
Image: Researchers identified eight new DNA pattern signatures that could help refine diagnostics and guide targeted therapy in breast cancer (image credit: 123RF)

Breast Cancer-Specific Signatures Link Genome Instability to Outcomes

Genomic instability is a hallmark of cancer, but most genomic analyses have relied on broad signatures shared across multiple malignancies, limiting their precision for individual tumor types.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.